Tick, tick, tick, counting down to BioMarine

The BioMarine Business Convention kicks off tomorrow so I thought I'd share this interview with chairman Pierre Erwes. Pierre gives us the lowdown on what promises to be a great event.  The article also features the convention's main sponsors. Click on the image to read the article or click here.

Click here to read the article

Thalocea Profile

Thalocea develops market intelligence tools in the sector of marine bio resources and marine renewable energies.  Since the beginning Thalocea and BioMarine have established a strong relationship to provide the industry with accurate strategic information. This year again, Thalocea is actively contributing to Biomarine.  To optimise your participation to the BioMarine business convention and the one to one partnership, Thalocea has prepared this company profile.  We look forward to actively working with you in London.

Novus Profile

Take a Closer Look at Novus Aquaculture

Novus creates animal and nutrition solution based on science. Grounded in lab research and tested in practical field studies, Novus products have long provided innovative solutions for the poultry, swine, dairy, beef and aqua industries. Over 2,500 clients in nearly 100 countries trust Novus to be an integral part of their daily animal agriculture operations.

Now that tradition of innovation continues with solutions for aquaculture. Novus monitors the evolving needs of the industry on a daily basis. Novus understands its many pressures, for which the talented researchers and developers are continuously working to create solutions. Driven by customer feedback, this team is focused on providing the industry with sustainable and cost-efficient solutions. Novus is dedicated to anticipating today what the industry will need tomorrow.

Aquaculture will soon become the world’s leading source of animal protein, providing wholesome nutrition to an ever-growing population. To produce the food that’s needed in a profitable, sustainable manner, the industry faces many significant challenges. Now and in the future, the industry can count on Novus as their partner in overcoming these challenges.

Click on the image to visit the Novus website

Novus: Investing in the Future of Aquaculture

Novus is committed to making Aquaculture production more efficient and profitable. The Novus staff, which includes nearly 80 research and development experts, dedicates itself to this mission every day. And by supporting graduate scholarships at leading aquaculture research institutions worldwide, Novus is also investing in the future of the industry.

Novus’s goal is to provide innovative total management solutions that optimize aquaculture production. Novus is dedicated to providing customized solutions that enhance the health and performance of your animals.

To learn more about our aquaculture solutions, contact your local Novus Sales Representative or Novus Customer Service. Outside of the U.S., call +1.314.576.8886, within the U.S., call 1.800.568.0088 or send an e-mail to aqua@novusint.com.

Olmix Profile

Founded in 1995 by Hervé Balusson, Olmix Group was born at the core of Brittany, in Bréhan (Morbihan) from the will to find natural alternatives to additives used in agriculture.

Its business is specially based on the development of natural additives based on seaweeds, trace-elements and clays towards Animal and Vegetal Nutrition and Health.

With its famous Amadéite^®, 100% natural biomaterial, Olmix has become one of the worldwide main specialists of green tech. One of the first green refineries in the world, the ULVANS Project, will soon be established in Brittany (France), and will industrially process products from algae. 

For 15 years, Olmix is involved in algae valorisation, and its philosophy is based on the belief that they are the new “Green Gold”. Olmix logo is by the way built with algae, more than a symbol, for a better life!

Click on the image to visit the Olmix website

Olmix is present in 60 countries throughout the world, has 250 employees and makes a turnover of 53,4 million Euros, of which 80 % of sales exported. Listed on the Paris Stock Exchange, Olmix has 7 production sites in Europe and its natural innovations lead the group to become a main reference in sustainable development with significant growth perspectives. Olmix Group’s strategy is in phase with regulations and environmental evolutions in the world.

BioMarine profile: Pronova BioPharma

Pronova is a global leader in research, development and manufacture of lipid therapies derived from nature.

The group's first commercialised product, Omacor/Lovaza, is branded in a number of countries (57) throughout Europe, Asia and in the USA. End-user sales has grown rapidly in all international  markets and the annual run rate at 31 December 2011 reached USD 1 380 million, according to IMS Health. The product is the first EU- and FDA-approved omega 3-derived prescription drug.

Marketing and distribution of Pronova's key product is currently licensed to both local and global pharmaceutical companies.

The company is in the process of developing several new, patentable lipid derivatives. The most advanced lipid derived pharmaceutical programme is in the area of combined dyslipidemia, the abnormal concentration of lipids and lipoproteins in the blood, for which the company has a product, PRC-4016, in clinical trials.

Pronova has also announced plans to enter the consumer health care and clinical nutrition markets, enabling the company to further leverage its position as the world's largest manufacturer of high grade omega-3 derived products.

Pronova's headquarters are located at Lysaker in Norway, while production takes place at state of-the-art manufacturing facilities at Sandefjord in Norway and in Kalundborg, Denmark. The company's shares are listed on Oslo Børs with the ticker code PRON.

Additional information is available here.